
7 Key Facts About a Rideshare Assault Lawsuit
Learn symptoms, eligibility, evidence, compensation, and filing steps for a rideshare assault lawsuit after an Uber or Lyft attack.

At Mass Tort Intake Center, we help law firms scale their caseloads by delivering exclusive, high-quality legal leadsacross a range of torts and personal injury cases — including Motor Vehicle Accidents (MVA).
We specialize in first-party lead generation, real-time qualification, and rapid delivery.
If you’re seeking dependable, compliant, and medically pre-qualified claimants — you’re in the right place.
Mass Tort Intake Center
Connecting Claimants. Empowering Law Firms.
We are a full-service intake and lead generation company focused exclusively on legal verticals. We work with select law firms across the U.S. to help them acquire new clients through a highly targeted and compliant lead funnel.
Here’s how we deliver value:
We don’t resell. We don’t broker. Every lead is first-party, exclusive, and delivered in real time.
We serve Plaintiff-side law firms nationwide that are actively acquiring new clients for:
We partner with firms ranging from boutique PI practices to national mass tort litigators.
We currently generate leads for the following verticals:
Motor Vehicle Accident (MVA)
Mass Tort Campaigns
New campaigns are added monthly. Custom targeting available.
We tailor your lead flow by tort type, state licensure, case criteria (e.g., injury severity, treatment, time since event), and volume.
Leads are vetted by intake agents or digital logic and passed to you within minutes, complete with contact details and case background.
You receive leads ready for sign-up — and we can facilitate live transfers, e-signed documents, or API delivery into your intake system.
Exclusive Leads Only – No sharing. No competing firms. You get the claimant — first and only.
Nationwide Coverage – We match leads by geography and firm criteria.
Transparent Intake Process – Every lead is verified by our trained agents or qualifying forms.
No Aggregators – We don’t buy from lead exchanges. We generate 100% of our traffic.
U.S.-Based Operations – All publishers, call centers, and personnel are based in the United States.
Flexible Volume Models – Scale up or pause based on your docket capacity.
Whether you’re a regional PI firm or a national MDL player, we’re here to fuel your growth with leads that convert and cases that settle.
Book a discovery call
Mass Tort Intake Center’s blog, your gateway to a wealth of knowledge and resources in the world of legal matters. Our blog section is dedicated to providing you with the latest insights, research, and expert advice to help you or your loved ones navigate the complex journey of legal claims. Attention! Time-sensitive lawsuits are now being filed! You may be entitled to financial compensation!

Learn symptoms, eligibility, evidence, compensation, and filing steps for a rideshare assault lawsuit after an Uber or Lyft attack.

Learn Roblox addiction lawsuit symptoms, eligibility, evidence, compensation, and filing steps for families considering a claim.

Learn talcum powder lawsuit symptoms, eligibility, evidence, compensation, and filing timelines if you used baby powder and developed cancer.

Learn Ozempic vision loss lawsuit signs, eligibility, evidence, compensation, and filing timelines if semaglutide affected your eyesight.

Learn hair relaxer lawsuit symptoms, eligibility, claims, compensation, evidence, and filing timelines for a possible cancer claim.

Learn about AFFF lawsuit settlement amounts, eligibility, and how to file a firefighting foam PFAS claim for potential compensation before deadlines.

Learn about paraquat lawsuit settlements, eligibility, symptoms, and how to file a claim for potential compensation before deadlines expire.

Learn about the LDS church abuse lawsuit, eligibility, compensation, evidence, and filing process. See if you qualify before time runs out.

Learn about the Depo-Provera lawsuit, symptoms, eligibility, and how to file a claim for possible compensation related to meningioma or brain tumor risks.